札幌北楡病院は、札幌市白石区にある病院。日本医工学治療学会の事務局所在地。

During the past decade, Sapporo Hokuyu Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sapporo Hokuyu Hospital" are "Primary Myelofibrosis" (4 trials), "Myelofibrosis" (3 trials), "Post Essential Thrombocythemia Myelofibrosis" (2 trials), "Post Polycythemia Vera Myelofibrosis" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Sapporo Hokuyu Hospital" in a lesser frequency.

Most popular intervention types in "Sapporo Hokuyu Hospital" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "parsaclisib" (2 trials), "placebo" (2 trials), "ruxolitinib" (2 trials) and "ACE-536" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sapporo Hokuyu Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Sapporo Hokuyu Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sapporo Hokuyu Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sapporo Hokuyu Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".